Interestingly, we found that nearly 80% of both healthy individuals and RA/PsA patients have CD4+ T-cell-reactivity to the HSP peptides tested, indicating the (expected) promiscuity of these peptides. Here, CD4 is linked to rheumatoid arthritis.